论文部分内容阅读
目的探讨依达拉奉对脑梗死患者神经功能及炎症因子的影响。方法 118例脑梗死患者,随机分为对照组和观察组,各59例。对照组给予脑梗死常规治疗;观察组加用依达拉奉注射液治疗。比较两组疗效。结果治疗前两组的神经功能缺损评分和超敏C反应蛋白(hs-CRP)相比较,差异无统计学意义(P>0.05),治疗后两组的神经功能缺损评分和hs-CRP相比较,观察组均优于对照组(P<0.05);两组总有效率相比较,观察组优于对照组(P<0.05)。结论依达拉奉可以改善脑梗死患者的神经功能,降低炎症因子水平,促进患者康复。
Objective To investigate the effect of edaravone on neurological function and inflammatory factors in patients with cerebral infarction. Methods 118 patients with cerebral infarction were randomly divided into control group and observation group, 59 cases each. The control group was given routine cerebral infarction treatment; the observation group was treated with edaravone injection. Compare the two groups curative effect. Results There was no significant difference between the two groups in neurological deficit scores and hs-CRP before treatment (P> 0.05). After treatment, the neurological deficit scores of both groups were significantly higher than those of hs-CRP (P <0.05). The total effective rate in the two groups was better than that in the control group (P <0.05). Conclusion Edaravone can improve the neurological function, reduce the level of inflammatory cytokines and promote the recovery of patients with cerebral infarction.